ketorolac has been researched along with olopatadine hydrochloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abelson, M; Deschenes, J; Discepola, M | 1 |
| Celik, T; Turkoglu, EB | 1 |
2 trial(s) available for ketorolac and olopatadine hydrochloride
| Article | Year |
|---|---|
Comparative evaluation of olopatadine ophthalmic solution (0.1%) versus ketorolac ophthalmic solution (0.5%) using the provocative antigen challenge model.
Topics: Acute Disease; Adult; Aged; Allergens; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Cross-Over Studies; Dibenzoxepins; Double-Blind Method; Female; Histamine H1 Antagonists; Humans; Ketorolac; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Safety; Seasons; Treatment Outcome | 1999 |
Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Conjunctivitis, Allergic; Dibenzoxepins; Drug Combinations; Female; Fluorometholone; Histamine H1 Antagonists, Non-Sedating; Humans; Ketorolac; Male; Middle Aged; Olopatadine Hydrochloride; Ophthalmic Solutions; Placebos; Seasons; Treatment Outcome; Young Adult | 2014 |